Viewing Study NCT03541902

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:05 AM
Ignite Modification Date: 2026-07-06 @ 1:41 AM
Study NCT ID: NCT03541902
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-01-09
First Post: 2018-05-16
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Malignant Neoplasms of Urinary Tract View
None Renal Cell Carcinoma View
None Chromophobe Renal Cell Carcinoma View
None Metastatic Renal Cell Carcinoma View
None Papillary Renal Cell Carcinoma View
None Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions View
None Sarcomatoid Renal Cell Carcinoma View
None Stage IV Renal Cell Cancer AJCC v8 View
None Unclassified Renal Cell Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Malignant Neoplasms of Urinary Tract View
None Renal cell carcinoma View
None Cabozantinib View
None XL-184 View
None XL184 View
None Sunitinib View
None Sunitinib Malate View
None SU011248 View
None Sutent View